Royce & Associates’s Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an HIMS.WS Stock Holding History

Royce & Associates’s Portfolio HIMS.WS Stock Details HIMS.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-266,666	Closed	-$893K	–	1053
2021 Q2	$893K	Hold	266,666	–	–	0.01%	859
2021 Q1	$1.17M	Buy	+266,666	New	+$1.74M	0.01%	834

Royce & Associates's HIMS.WS Position: Q3 2021 in Review

Royce & Associates sold out of Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an (HIMS.WS) in Q3 2021, closing a stake of 266,666 shares — an estimated $893K sold.

Royce & Associates first reported a position in HIMS.WS in Q1 2021 and held it in 2 quarters. The position peaked at $1.17M in Q1 2021. 0 funds tracked by Wall St. Rank hold HIMS.WS as of Q3 2021.

Royce & Associates reported no remaining Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an position as of Q3 2021 after selling out during the quarter.
Royce & Associates sold 266,666 Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an shares in Q3 2021, an estimated $893K.
Royce & Associates first reported a position in Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an in Q1 2021 and held it in 2 quarters.
Royce & Associates's Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an position peaked at $1.17M in Q1 2021.
0 funds tracked by Wall St. Rank held Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an as of Q3 2021.

Based on Royce & Associates's 13F filing for Q3 2021, filed 10 Nov 2021.